We are live on
!
Find out more
JBIO
Jade Biosciences
JBIO
JBIO
41 hedge funds and large institutions have $453M invested in Jade Biosciences in 2021 Q3 according to their latest regulatory filings, with 29 funds opening new positions, 3 increasing their positions, 4 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
383% more first-time investments, than exits
New positions opened: 29 | Existing positions closed: 6
128% more funds holding
Funds holding: 18 → 41 (+23)
2.53% more ownership
Funds ownership: 0% → 2.53% (+2.5%)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
0% less capital invested
Capital invested by funds: $454M → $453M (-$1.86M)
25% less repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 4
Holders
41
Holders Change
+23
Holders Change %
+127.78%
% of All Funds
0.72%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.04%
New
29
Increased
3
Reduced
4
Closed
6
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$12.5M |
| 2 |
BlackRock
New York
|
+$7.73M |
| 3 |
BBA
Baker Bros. Advisors
New York
|
+$3.58M |
| 4 |
PPA
Parametric Portfolio Associates
Seattle,
Washington
|
+$2.27M |
| 5 |
State Street
Boston,
Massachusetts
|
+$2.01M |
